These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21340422)

  • 1. [Methemoglobinemia in patients with Plasmodium vivax receiving oral therapy with primaquine].
    Ferreira ME; Gomes Mdo S; Vieira JL
    Rev Soc Bras Med Trop; 2011; 44(1):113-5. PubMed ID: 21340422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine].
    Santana MS; da Rocha MA; Arcanjo AR; Sardinha JF; Alecrim WD; Alecrim Md
    Rev Soc Bras Med Trop; 2007; 40(5):533-6. PubMed ID: 17992408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
    Carmona-Fonseca J; Alvarez G; Maestre A
    Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day].
    Silva MC; Santos EB; Costal EG; Filho MG; Guerreiro JF; Póvoa MM
    Rev Soc Bras Med Trop; 2004; 37(3):215-7. PubMed ID: 15330059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
    Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report.
    Savargaonkar D; Ahmed MZ; Anvikar AR; Valecha N
    J Vector Borne Dis; 2017; 54(3):287-290. PubMed ID: 29097646
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
    Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
    J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
    Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
    Silachamroon U; Krudsood S; Treeprasertsuk S; Wilairatana P; Chalearmrult K; Mint HY; Maneekan P; White NJ; Gourdeuk VR; Brittenham GM; Looareesuwan S
    Am J Trop Med Hyg; 2003 Jul; 69(1):14-8. PubMed ID: 12932090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
    Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
    Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
    Tang ASO; Soo XY; Yeo ST; Mansor NA; Chew LP; Chua HH
    J R Coll Physicians Edinb; 2021 Jun; 51(2):146-148. PubMed ID: 34131671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine-induced severe methemoglobinemia developed during treatment of Plasmodium vivax malarial infection in an Indian family associated with a novel mutation (p.Agr57Trp) in the CYB5R3 gene.
    Kedar P; Warang P; Sanyal S; Devendra R; Ghosh K; Colah R
    Clin Chim Acta; 2014 Nov; 437():103-5. PubMed ID: 25058800
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal Primaquine-Induced Hemolysis in a Patient With Plasmodium vivax Malaria and G6PD A(-) Variant in the Brazilian Amazon.
    Monteiro WM; Moura-Neto JP; Recht J; Bassat Q; Lacerda MV
    Clin Infect Dis; 2016 May; 62(9):1188. PubMed ID: 26826373
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.
    Setyadi A; Arguni E; Kenangalem E; Hasanuddin A; Lampah DA; Thriemer K; Anstey NM; Sugiarto P; Simpson JA; Price RN; Douglas NM; Poespoprodjo JR
    Malar J; 2019 Apr; 18(1):111. PubMed ID: 30940140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How much primaquine is needed to eradicate Plasmodium vivax hypnozoites?].
    Muñoz J; Velasco M; Alonso D; Valls ME; Corachán M; Gascón J
    Enferm Infecc Microbiol Clin; 2006 Jan; 24(1):29-30. PubMed ID: 16537060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.